112.1 Early xeno-derived cell-free DNA elevation as a noninvasive biomarker of kidney xenograft rejection in pig-to-nonhuman primate xenotransplantation
Mr. JOON YOUNG JANG, Korea
112.2 Immunopeptidomic identification of SLA-derived HLA class II ligands recognized by human T cells, using a strategy adapted for xenotransplantation
Dr. Kenta Iwasaki, Japan
112.3 Establishment of a designated pathogen-free (DPF) donor pig population of genetically edited pigs in Neijiang, China
Mr. Xing Xiangyang, People's Republic of China
112.4 SLA antibody screening using Auckland island pig cells: Toward standardized diagnostics for xenotransplantation
Dr. Gisella L. Puga Yung, Switzerland
112.5 Standardization of multiplex qPCR assays for detection of PCMV and PCV2 in organ donor pigs
Dr. Ernesto Goulart, Brazil
112.6 Successful somatic support of brain-dead decedents for xenotransplantation research: A systematic review and case series
Dr. Karen Khalil, United States
112.7 Optimized cryopreservation of porcine pancreatic islet cells: A novel protocol for single-cell biobanking